News Focus
News Focus
icon url

Investor2014

09/30/21 5:48 AM

#331508 RE: XenaLives #331507

I agree.

Anavex is not facing any uphill work or cost for marketing, sales or partnership deals should one or more of their compounds gain approval in rare diseases.
icon url

plexrec

09/30/21 7:44 AM

#331511 RE: XenaLives #331507

Xena--" no problem "getting the word out":"--great article--thanks for posting--now for approval !!!!!! It's time !!